| |
| |
|
| Insider
Information: |
Knickerbocker Aron Marc |
| Relationship: |
President & CEO, Direc... |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
42,057 |
|
|
Indirect Shares
|
200,299 |
|
|
| Direct
Value |
$1,598,166 |
|
|
|
Indirect Value
|
$7,611,362 |
|
|
| Total
Shares |
242,356 |
|
|
| Total
Value |
$9,209,528 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Five Prime Therapeutics Inc |
FPRX |
President & CEO, Direc... |
2019-09-01 |
42,057 |
2019-09-01 |
200,299 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
43 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| FPRX |
Five Prime Therapeutics I... |
SVP & Chief Business Officer |
• • – |
2015-04-30 |
4 |
A |
$0.00 |
$0 |
D/D |
7,480 |
45,808 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
EVP & Chief Business Officer |
• • – |
2015-08-20 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
179,965 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
EVP and Chief Business Officer |
• • – |
2016-08-25 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
193,718 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
Chief Operating Officer |
• • – |
2016-09-08 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
185,889 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
Chief Operating Officer |
• • – |
2017-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
14,839 |
189,881 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
President & CEO |
• • – |
2018-09-28 |
4 |
A |
$0.00 |
$0 |
D/D |
1,775 |
197,920 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
President & CEO |
• • – |
2019-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
25,844 |
220,907 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
EVP and Chief Business Officer |
• • – |
2016-09-01 |
4 |
D |
$44.74 |
$797,669 |
D/D |
(17,829) |
175,889 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
Chief Operating Officer |
• • – |
2017-01-03 |
4 |
D |
$48.60 |
$143,710 |
D/D |
(2,957) |
175,811 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
Chief Operating Officer |
• • – |
2017-03-01 |
4 |
D |
$44.77 |
$874,313 |
D/D |
(19,529) |
170,352 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
Chief Operating Officer |
• • – |
2017-09-01 |
4 |
D |
$34.34 |
$126,509 |
D/D |
(3,684) |
160,295 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
President & CEO |
• • – |
2018-09-01 |
4 |
D |
$14.00 |
$46,284 |
D/D |
(3,306) |
192,061 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
President & CEO |
• • – |
2018-09-28 |
4 |
D |
$13.92 |
$13,280 |
D/D |
(954) |
196,966 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
President & CEO |
• • – |
2019-02-05 |
4 |
D |
$11.43 |
$34,244 |
D/D |
(2,996) |
195,063 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
President & CEO |
• • – |
2019-02-26 |
4 |
D |
$11.95 |
$29,421 |
D/D |
(2,462) |
218,445 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
President & CEO |
• • – |
2019-09-01 |
4 |
D |
$5.43 |
$17,952 |
D/D |
(3,306) |
42,057 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
President & CEO |
• • – |
2018-06-08 |
4 |
GD |
$0.00 |
$0 |
I/I |
845 |
14,238 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
SVP & Chief Business OfficerOf |
• – – |
2013-09-17 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
35,073 |
|
- |
|
| FPRX |
Five Prime Therapeutics I... |
SVP & Chief Business Officer |
• • – |
2014-12-10 |
4 |
OE |
$4.56 |
$91,925 |
D/D |
14,366 |
34,771 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
SVP & Chief Business Officer |
• • – |
2015-04-10 |
4 |
OE |
$5.54 |
$19,706 |
D/D |
3,557 |
38,328 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
SVP & Chief Business Officer |
• • – |
2015-06-24 |
4 |
OE |
$5.54 |
$327,127 |
D/D |
38,084 |
83,892 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
SVP & Chief Business Officer |
• • – |
2015-07-29 |
4 |
OE |
$5.54 |
$93,438 |
D/D |
16,497 |
100,389 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
SVP & Chief Business Officer |
• • – |
2015-08-11 |
4 |
OE |
$5.54 |
$16,620 |
D/D |
3,000 |
103,389 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
EVP & Chief Business Officer |
• • – |
2015-09-25 |
4 |
OE |
$5.54 |
$17,091 |
D/D |
2,708 |
182,673 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
Chief Operating Officer |
• • – |
2017-06-16 |
4 |
OE |
$5.54 |
$45,871 |
D/D |
8,280 |
163,548 |
0 |
- |
|
43 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
